Mernova secures licence for medicinal cannabis in Canada The new licence will take Mernova and Creso Pharma into the huge medicinal cannabis market in Canada, with the potential to unlock the recurring revenue model.
In a major development, global medicinal cannabis company, Creso Pharma (ASX:CPH), announced that its wholly-owned subsidiary Mernova has secured a licence extension to sell medicinal cannabis in Canada.
This will now allow Mernova to enter the lucrative medicinal cannabis market in Canada, in addition to the existing recreational market licence it has already received from Health Canada in May 2020
https://stockhead.com.au/health/creso-pharmas-canadian-subsidiary-mernova-secures-licence-for-medicinal-cannabis-in-canada/